Department of Clinical Neurosciences, Division of Neurosurgery, Geneva University Hospitals, Geneva, Switzerland.
Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Neurosurg Rev. 2020 Dec;43(6):1547-1553. doi: 10.1007/s10143-019-01181-6. Epub 2019 Oct 29.
Sphenoid wing meningiomas are generally considered as skull base meningiomas (SBMs). However, given their surgical similarities with non-skull base meningiomas (NSBMs), we hypothesized that lateral sphenoid wing meningiomas (LSWMs) without bone invasion (BI) should be considered as NSBMs. N = 65 LSWMs without BI operated between 1990 to 2010 at a single-center were compared to N = 352 NSBMs, represented by convexity meningiomas (CMs), and to N = 23 SBMs, represented by spheno-orbital meningiomas (SOMs), with respect to baseline demographics, clinical presentations, Simpson grades, complications, adjuvant therapies, as well as overall survival (OS) and progression-free survival (PFS). Only WHO grade I meningiomas were included. No significant differences in baseline demographics, clinical presentation, or pre-operative KPS were found between the three groups. Simpson grade 1-3 was achieved in 90.1% of LSWMs, 97.1% in CMs (p = 0.05), and 82.6% in SOMs (p = 0.23). There were no significant differences in postoperative infection, hematoma, neurological worsening, 30-day mortality, or OS between the three groups. Lower re-treatment rates were observed in LSWMs and CMs compared to SOMs (p = 0.06). With respect to PFS, there was no significant difference between LSWMs and CMs (89.1% and 88.5% at 5 years, respectively), whereas PFS was significantly higher in LSWMs than in SOMs (79% at 5 years) (p = 0.05). LSWMs without BI should be considered as an intermediate entity between NSBMs and SBMs. LSWMs are similar to SOMs with respect to extent of resection, but more similar to CMs with respect to re-treatment rates and PFS.
蝶骨翼脑膜瘤通常被认为是颅底脑膜瘤(SBMs)。然而,鉴于它们与非颅底脑膜瘤(NSBMs)在手术上的相似性,我们假设没有骨侵犯(BI)的外侧蝶骨翼脑膜瘤(LSWMs)应被视为 NSBMs。在单中心,我们比较了 1990 年至 2010 年间手术治疗的 65 例无 BI 的 LSWMs 与 352 例凸面脑膜瘤(CMs)代表的 NSBMs 以及 23 例蝶眶脑膜瘤(SOMs)代表的 SBMs,比较了它们的基线人口统计学特征、临床表现、Simpson 分级、并发症、辅助治疗以及总生存率(OS)和无进展生存率(PFS)。仅包括 WHO 分级 I 级脑膜瘤。三组间基线人口统计学特征、临床表现或术前 KPS 无显著差异。LSWMs 中 Simpson 分级 1-3 级占 90.1%,CMs 中占 97.1%(p=0.05),SOMs 中占 82.6%(p=0.23)。三组间术后感染、血肿、神经恶化、30 天死亡率和 OS 无显著差异。与 SOMs 相比,LSWMs 和 CMs 的再治疗率较低(p=0.06)。关于 PFS,LSWMs 与 CMs 之间无显著差异(分别为 5 年时的 89.1%和 88.5%),而 LSWMs 与 SOMs 相比 PFS 显著更高(5 年时的 79%)(p=0.05)。无 BI 的 LSWMs 应被视为 NSBMs 和 SBMs 之间的中间实体。LSWMs 在切除范围方面与 SOMs 相似,但在再治疗率和 PFS 方面与 CMs 更相似。